White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report

The decision comes the day before the Senate's Health, Education, Labor and Pensions Committee was scheduled to vote on her nomination.

Published: November 17, 2026 8:34pm

The White House reportedly pulled its nomination Tuesday for Heidi Overton to lead  the Food and Drug Administration over concerns that she would not have the congressional support to get confirmed. 

President Donald Trump nominated Overton for the post in August. She is a physician who serves as the deputy director of the White House Domestic Policy Council. 

A senior administration official told Axios that Overton did not have enough support to be confirmed as the next FDA commissioner after she faced skepticism from some Republicans over her role in the administration's efforts to change childhood vaccine recommendations.

"FDA nominee Heidi Overton lacks the support on the Hill to move forward with her confirmation," the official said. "We need to go in a new direction at FDA, and everybody fully supports [Health] Secretary [Robert F.] Kennedy Jr.'s vision to Make America Healthy Again and get back to a more populist and common-sense approach to health in America."

The decision comes the day before the Senate's Health, Education, Labor and Pensions Committee was scheduled to vote on her nomination. 

The agency has been led by acting FDA Commissioner Kyle Diamantas since Marty Makary resigned in May.

Misty Severi is a news reporter for Just The News. You can follow her on X for more coverage.

The Facts Inside Our Reporter's Notebook

Just the News Spotlight

Support Just the News